RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Creo Medical Group Stock

Creo Medical Group Employees 2024

Creo Medical Group Employees

175

Ticker

CREO.L

ISIN

GB00BZ1BLL44

WKN

A2DH40

In 2024, Creo Medical Group employed 175 people, a 0% change from the 175 number of employees in the previous year.

Creo Medical Group Aktienanalyse

What does Creo Medical Group do?

Creo Medical Group PLC is a British medical technology company that was founded in 2003 and is based in Chepstow, Wales. The company specializes in the development and marketing of innovative medical devices. Creo Medical aims to improve the lives of healthcare professionals and patients by providing them with state-of-the-art technology. The company's business model focuses on research, development, and sales of innovative medical devices. Their goal is to provide doctors with the most advanced technology to facilitate their work. Creo Medical offers a wide range of devices for endoscopic surgery. They follow an asset-light model, outsourcing production to save costs and increase efficiency. Creo Medical was founded in 2003 by a team of professionals consisting of doctors and engineers. Their objective was to promote the development of cutting-edge technology for the medical industry and improve the treatment of patients worldwide. The company quickly gained momentum and received its first patent in 2014. Their product range includes endoscopes and electrosurgical devices for endoscopic surgery. Endoscopes are used to visualize the internal surfaces of the body through a flexible tube inserted through a small incision. This type of technology is used in surgery, particularly in gastrointestinal and gynecological areas. Electrosurgical devices are used in heart surgery and to prevent bleeding during operations. Creo Medical operates in various sectors where their products are utilized: 1. Gastroenterology: focusing on the diagnosis and treatment of digestive tract diseases. 2. Laparoscopic surgery: a surgical technique that uses a few small incisions to introduce surgical instruments into the body. 3. Gynecology: dealing with the diagnosis and treatment of diseases in the female reproductive system. 4. Urology: involving the treatment of diseases in the urinary tract and male reproductive system. Creo Medical serves multiple markets and recently announced the acquisition of Albyn Medical, a leading British manufacturer and distributor of medical devices. The company reported a 68% increase in revenue to £8.8 million in 2020, attributing the growth to growing demand for laparoscopic and gastroenterological products. Creo Medical's stock was listed on London's AIM in 2018. In conclusion, Creo Medical is a British medical technology company specializing in the development, manufacturing, and marketing of medical devices used in various medical fields. Their advanced technologies contribute to breakthroughs in surgery, making procedures more precise and gentle. Creo Medical has become a significant player in the British and international medical industry and will continue to play an important role in this sector. Creo Medical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Creo Medical Group's Employee Base

Creo Medical Group's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Creo Medical Group's operational capacity and future potential.

Year-to-Year Comparison

Assessing Creo Medical Group's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Creo Medical Group's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Creo Medical Group’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Creo Medical Group stock

How many employees does Creo Medical Group have this year?

Creo Medical Group has 175 undefined employees this year.

How many employees did Creo Medical Group have compared to the previous year?

Compared to the previous year, Creo Medical Group had 0% more employees.

What impact did the number of employees have on the company Creo Medical Group?

The number of employees has a direct impact on the efficiency and productivity of Creo Medical Group. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Creo Medical Group?

The number of employees can also have an impact on investors of Creo Medical Group, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Creo Medical Group affect the company?

An increase in equity of Creo Medical Group can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Creo Medical Group's equity affect the company?

A reduction in equity of Creo Medical Group can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Creo Medical Group?

Some factors that can influence the equity of Creo Medical Group include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Creo Medical Group so important for investors?

The equity of Creo Medical Group is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Creo Medical Group influence the company?

The number of employees at Creo Medical Group can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Creo Medical Group evolved in recent years?

In recent years, the number of employees at Creo Medical Group has changed by 0.

How many employees does Creo Medical Group currently have?

Creo Medical Group currently has 175 undefined employees.

Why is the number of employees important for investors of Creo Medical Group?

The number of employees is important for investors of Creo Medical Group as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Creo Medical Group take to change the number of employees?

To change the number of employees, Creo Medical Group can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Creo Medical Group pay?

Over the past 12 months, Creo Medical Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Creo Medical Group is expected to pay a dividend of 0 GBP.

What is the dividend yield of Creo Medical Group?

The current dividend yield of Creo Medical Group is .

When does Creo Medical Group pay dividends?

Creo Medical Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Creo Medical Group?

Creo Medical Group paid dividends every year for the past 0 years.

What is the dividend of Creo Medical Group?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Creo Medical Group located?

Creo Medical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Creo Medical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Creo Medical Group from 7/31/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.

When did Creo Medical Group pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of Creo Medical Group in the year 2023?

In the year 2023, Creo Medical Group distributed 0 GBP as dividends.

In which currency does Creo Medical Group pay out the dividend?

The dividends of Creo Medical Group are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Creo Medical Group

Our stock analysis for Creo Medical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Creo Medical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.